State of Wyoming Has $478,000 Stock Position in Siga Technologies Inc. $SIGA

Key Points

• The State of Wyoming increased its stake in Siga Technologies Inc. by 90.9% during the first quarter, now owning 87,203 shares valued at approximately $478,000.
• A number of institutional investors also boosted their positions in Siga Technologies during the same period, with Russell Investments Group raising its stake by an astonishing 6,344.8%.
• Siga Technologies has a current market capitalization of $600.81 million and reported earnings of $0.49 EPS with revenues of $81.12 million for the latest quarter.

State of Wyoming raised its holdings in shares of Siga Technologies Inc. (NASDAQ:SIGA - Free Report) by 90.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 87,203 shares of the company's stock after purchasing an additional 41,535 shares during the quarter. State of Wyoming owned approximately 0.12% of Siga Technologies worth $478,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC lifted its position in Siga Technologies by 52.9% in the first quarter. Hotchkis & Wiley Capital Management LLC now owns 3,158,320 shares of the company's stock valued at $17,308,000 after purchasing an additional 1,093,080 shares during the last quarter. Martingale Asset Management L P grew its stake in shares of Siga Technologies by 3.2% in the first quarter. Martingale Asset Management L P now owns 86,157 shares of the company's stock worth $472,000 after acquiring an additional 2,684 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Siga Technologies by 51.7% during the first quarter. Wellington Management Group LLP now owns 182,328 shares of the company's stock valued at $999,000 after purchasing an additional 62,103 shares in the last quarter. American Century Companies Inc. boosted its position in shares of Siga Technologies by 7.8% during the first quarter. American Century Companies Inc. now owns 1,370,660 shares of the company's stock valued at $7,511,000 after buying an additional 98,688 shares during the last quarter. Finally, Russell Investments Group Ltd. boosted its position in shares of Siga Technologies by 6,344.8% during the first quarter. Russell Investments Group Ltd. now owns 9,925 shares of the company's stock valued at $54,000 after buying an additional 9,771 shares during the last quarter. Hedge funds and other institutional investors own 55.40% of the company's stock.

Siga Technologies Price Performance

Shares of SIGA stock traded down $0.11 during trading on Friday, reaching $8.39. The company's stock had a trading volume of 114,186 shares, compared to its average volume of 476,895. Siga Technologies Inc. has a 1-year low of $4.95 and a 1-year high of $9.62. The stock's 50-day moving average price is $7.59 and its 200 day moving average price is $6.48. The company has a market capitalization of $600.45 million, a price-to-earnings ratio of 7.41 and a beta of 0.95.

Siga Technologies (NASDAQ:SIGA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.49 earnings per share for the quarter. The firm had revenue of $81.12 million during the quarter. Siga Technologies had a return on equity of 40.52% and a net margin of 45.73%. On average, sell-side analysts anticipate that Siga Technologies Inc. will post 1.04 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised Siga Technologies from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 9th.

About Siga Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.